Advertisement
YOU ARE HERE: LAT HomeCollectionsSerzone Drug
IN THE NEWS

Serzone Drug

FEATURED ARTICLES
NATIONAL
May 20, 2004 | From Times Wire Reports
Bristol-Myers Squibb will stop selling its controversial antidepressant Serzone in the United States starting next month, a company spokesman said. Serzone has been linked to dozens of cases of liver failure and injury, including at least 20 deaths. The drug, the subject of several lawsuits, is one of 17 to be discontinued due to poor sales and growing competition, said Robert Hutchison, a spokesman for Bristol-Myers.
ARTICLES BY DATE
NATIONAL
May 20, 2004 | From Times Wire Reports
Bristol-Myers Squibb will stop selling its controversial antidepressant Serzone in the United States starting next month, a company spokesman said. Serzone has been linked to dozens of cases of liver failure and injury, including at least 20 deaths. The drug, the subject of several lawsuits, is one of 17 to be discontinued due to poor sales and growing competition, said Robert Hutchison, a spokesman for Bristol-Myers.
Advertisement
BUSINESS
January 6, 1995 | Times Wire Services
Bristol-Myers Squibb Co. said Thursday that it has received approval from the Food and Drug Administration to sell a new antidepressant, Serzone, which will be in pharmacies within a few weeks. The company said the drug differs from other antidepressants both chemically and in the way it operates.
BUSINESS
January 6, 1995 | Times Wire Services
Bristol-Myers Squibb Co. said Thursday that it has received approval from the Food and Drug Administration to sell a new antidepressant, Serzone, which will be in pharmacies within a few weeks. The company said the drug differs from other antidepressants both chemically and in the way it operates.
Los Angeles Times Articles
|